Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2025-12-25 @ 2:34 AM
NCT ID:
NCT06914934
Eligibility Criteria:
Inclusion Criteria:
* Men and women aged 45-75 years.
* Clinically documented stable ischemic heart disease (≥6 months post-myocardial infarction or post-revascularization).
* On stable, guideline-recommended cardiac medications (e.g., statins, beta-blockers, ACE inhibitors).
* Elevated hs-CRP (\>2 mg/L) or impaired endothelial function (FMD \<7%) at baseline (optional enrichment criterion).
* Able and willing to give written informed consent.
Exclusion Criteria:
* Heart failure with reduced ejection fraction \<30% or New York Heart Association (NYHA) class III-IV.
* Severe hepatic or renal dysfunction.
* Decompensated diabetes (e.g., HbA1c \>10%).
* Current or recent (past 3 months) use of high-dose antioxidant/anti-inflammatory supplements (other than a standard multivitamin).
* Known allergy or intolerance to resveratrol.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
45 Years
Maximum Age:
75 Years
Study:
NCT06914934
Study Brief:
Protocol Section:
NCT06914934